Mary Beth Moynihan’s public career begins with numbers. Economics and mathematics at Williams College. Operations management at Wharton. An early stint reading the machinery of business as an auditor and financial analyst at Digital Equipment Corporation. Then strategy work at Braxton Associates, Deloitte & Touche’s consulting shop, where the assignment was to understand a business well enough to tell it where to go next.
Numbers, however, are only the opening dialect. Moynihan’s career became an exercise in translation: between a medical device and the person expected to use it, between an acquisition opportunity and a corporate portfolio, between a promising technology and the evidence needed to make it available, between a global company and the many audiences deciding whether to trust it. Her titles changed because the rooms changed. The useful skill was learning how to carry meaning from one room into another.
She arrived at Boston Scientific in 1997 as a marketer. Nearly three decades later, her public profile describes her as leading the company’s global Corporate Affairs team. Between those points sits a deliberately untidy line: product marketing, business development, corporate planning, enterprise strategy, brand, digital marketing, market access and customer experience. It is the sort of path that looks obvious only after somebody has cleaned it up for a biography.
The long way around is sometimes the shortcut
Moynihan spent her first years in Boston Scientific’s Peripheral Interventions business, eventually becoming director of product marketing. Then she moved toward deals. She directed business development for the cardiovascular businesses, became a vice president in the same field and, by 2010, shifted again into corporate strategic planning and research. Two years later she was senior vice president of enterprise strategy and marketing.
Read as a sequence, the moves resemble a curriculum. Product marketing supplied intimacy with the offering and customer. Business development demanded a view of what the company should add. Corporate planning required a view of the whole enterprise. Marketing and market access brought the work back toward communication, evidence and availability. Corporate affairs widened the brief once more, toward the way an institution speaks, listens and acts in public.
marketing
development
strategy
marketing
access
affairs
This is where Moynihan’s advice about the strategic detour earns its keep. She has argued that a lateral move can be an investment when it fills an experience gap. A title may move sideways while capability moves forward. The only way to know whether the bargain makes sense is to have a destination in mind.
“Don’t rule out a short-term ‘detour’ if it helps you build the long-term skillset you need.”Mary Beth Moynihan
Three verbs and a blank sheet of paper
In 2022, Moynihan published her method for taking control of a career. It contains three steps and almost no corporate incense. Own it. Define it. Invest in it. The first step asks a person to sketch a long-term vision, then work backward through the experiences and accomplishments required to reach it. Mentors and leaders can help refine that picture. They cannot draw it for you.
Draw the map
Name a destination, work backward and ask specific questions of people who can sharpen the route.
Choose your score
Decide what success means personally and professionally, near the overlap of ability and genuine interest.
Buy the missing skill
Use education, stretch work or a lateral move to close the gaps between today’s résumé and tomorrow’s work.
The second step is more subversive than it appears. Defining success for yourself means refusing the convenient scoreboards supplied by everyone else. Moynihan advises looking for the intersection of what you do well and what absorbs you. The definition can change. It should not be abandoned simply because a louder person values something different.
Then comes the bill. Investment may mean part-time study, a stretch assignment or a sideways move that builds a missing muscle. Her formulation treats time and effort as capital rather than punishment. It also makes patience easier to defend. When a move belongs to a larger design, the temporary inconvenience has a job.
There is a generosity built into the framework. Individuals own their plans, but leaders must create the conditions in which those plans can be discussed. Moynihan has written that transparency about responsibilities outside work can deepen relationships and improve conversations about priorities. Ambition need not require pretending to be unencumbered. A useful workplace sees the whole calendar.
Innovation without a magic trick
At the first MedExecWomen conference in 2019, Moynihan moderated a panel about the barriers to innovation inside large medical-technology companies. The audience poll refused to produce a single villain. Thirty percent chose the pressure to remain inside the corporate comfort zone. Nearly 27 percent pointed to homogenous teams. A quarter identified teams without enough decision-making power.
The proposed remedies were equally divided. Some wanted time, resources and formal programs. Others wanted more appetite for risk. Another group preferred to begin with customer insight. Moynihan did not force the room into false agreement. She concluded that meaningful innovation has no single path, then offered a compass: ground the work in the journeys of the people it is for, listen to customers and empower teams to act.
The distinction matters. Research without authority becomes a handsome document. Authority without context becomes energetic confusion. Resources without either acquire snacks and meeting rooms. An operator’s task is to connect the three. Moynihan’s career has repeatedly occupied those seams, places where evidence, customer understanding and organizational permission must meet before an idea can move.
“In reality, there’s no single path to meaningful innovation.”Mary Beth Moynihan
Build the room, then hold the door
MedExecWomen itself began as an answer to a missing room. Moynihan was among the early leaders enlisted to help build the community. Its first New York meeting attracted 83 women through word of mouth. By 2024, its gathering in Boston drew more than 200. The numbers describe demand, but the more interesting detail is the mechanism. One executive told another. A private need became shared infrastructure.
Her work outside the corporate job follows a similar logic. She has served with MedExecWomen, joined the board of the Massachusetts Medical Device Industry Council and become a trustee of the Boys & Girls Clubs of Boston. At Boston Scientific, she has sponsored employee groups and an internal innovation program. Different rooms, same practical question: who has the access, context or permission to take the next step?
In 2017, Boston Scientific’s collaboration with a return-to-work program offered another example. Moynihan described experienced women returning after career breaks as a talent pool that companies struggled to find and candidates struggled to navigate. The problem was not an absence of ability. It was a broken bridge between ability and opportunity. Building that bridge is less glamorous than declaring a talent shortage, and considerably more useful.
Her public comments in 2026 sharpened the point. Marking International Women’s Day, she promised time and advocacy so women could define their own version of success, invest in it boldly and reach the opportunities needed to bring it to life. The phrasing joins the two halves of her philosophy. A person must own the plan. An institution must make opportunity reachable.
The plot is the accumulation
Corporate biographies encourage us to see careers as a procession of nouns: analyst, director, vice president, chief marketing officer. Moynihan’s framework is built from verbs. Own. Define. Invest. Ground. Empower. Advocate. Verbs reveal movement, and movement is what the polished résumé tends to hide.
Her tenure at Boston Scientific is long enough to tempt a simple story about loyalty. The better story is about range. Staying did not mean repeating. Each assignment offered a different vantage point on how an idea becomes a product, a portfolio choice, an economic case, a message and finally an institutional promise. The organization remained the same while the scale of the question expanded.
There is no promise that a plan will make a career tidy. Moynihan explicitly leaves room for revision, sacrifice and routes that bend. Planning is not fortune-telling. It is a way to judge the next imperfect option against something more durable than applause. The map earns its value precisely when the road does not resemble it.
The lesson available for theft is pleasantly unromantic. Write down where you want to go. List what the person doing that work must know. Circle the gaps. Ask people you trust to challenge the list. Then choose the next move partly for the capability it buys. A career may still surprise you. At least the surprises will meet someone who has packed.